| Literature DB >> 33353064 |
Matteo Trovato1,2, Vibha Patil1, Maja Gehre1,2, Kyung Min Noh1.
Abstract
The systematic mutation of histone 3 (H3) genes in model organisms has proven to be a valuable tool to distinguish the functional role of histone residues. No system exists in mammalian cells to directly manipulate canonical histone H3 due to a large number of clustered and multi-loci histone genes. Over the years, oncogenic histone mutations in a subset of H3 have been identified in humans, and have advanced our understanding of the function of histone residues in health and disease. The oncogenic mutations are often found in one allele of the histone variant H3.3 genes, but they prompt severe changes in the epigenetic landscape of cells, and contribute to cancer development. Therefore, mutation approaches using H3.3 genes could be relevant to the determination of the functional role of histone residues in mammalian development without the replacement of canonical H3 genes. In this review, we describe the key findings from the H3 mutation studies in model organisms wherein the genetic replacement of canonical H3 is possible. We then turn our attention to H3.3 mutations in human cancers, and discuss H3.3 substitutions in the N-terminus, which were generated in order to explore the specific residue or associated post-translational modification.Entities:
Keywords: H3; H3.3; PTMs; chromatin; epigenetics; histone variants; histones; post-translational modifications
Mesh:
Substances:
Year: 2020 PMID: 33353064 PMCID: PMC7766983 DOI: 10.3390/cells9122716
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600